Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript
Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.37, expectations were $-0.11. Sarepta Therapeutics, Inc.
Sarepta Therapeutics Inc. (SRPT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 18,021 | $2,332,998 | +33% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $78.81 | 40,000 | Director | 140,000 | 2023-11-03 | Filing | |
| $78.81 | 10,000 | Director | 10,000 | 2023-11-03 | Filing | |
| $81.26 | 200 | Officer, Director | 390,307 | 2023-11-03 | Filing | |
| $80.33 | 3,884 | Officer, Director | 390,107 | 2023-11-03 | Filing | |
| $79.70 | 11,060 | Officer, Director | 386,223 | 2023-11-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $140.00 | 3,635 | 18,125 | 2024-05-02 | Filing | ||
| $122.39 | 100 | 22,840 | 2024-03-08 | Filing | ||
| $123.10 | 11,745 | 22,940 | 2024-03-08 | Filing | ||
| $123.85 | 3,155 | 34,685 | 2024-03-08 | Filing | ||
| $122.93 | 761 | 7,516 | 2024-03-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,816,124 | $850,138,837 | 0.01% | |
| 2. | 6,211,792 | $599,003,103 | 0.01% | |
| 3. | 5,345,785 | $515,482,888 | 0.3% | |
| 4. | 4,741,485 | $457,221,399 | 0.1% | |
| 5. | 4,127,610 | $398,025,433 | 0.07% |
News See All
5 Unstoppable Stocks That Will Make You Richer
In this article, we discuss the 5 unstoppable stocks that will make you richer.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Billionaire Ken Fisher and Corporate Insiders Are Buying These 10 Stocks
In this article, we will take a detailed look at Billionaire Ken Fisher and Corporate Insiders Are Buying These 10 Stocks.
Billionaire Ray Dalio and Insiders Love These 10 Stocks
In this article, we will take a detailed look at Billionaire Ray Dalio and Insiders Love These 10 Stocks. For a quick overview of such stocks, read our article Billionaire Ray Dalio and Insiders Love...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2023 Earnings Call Transcript
Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.47, expectations were $-0.03. Sarepta Therapeutics, Inc.
5 Best Small-Cap Growth Stocks to Invest In
In this piece, we will take a look at the five best small-cap growth stocks to invest in.
Growth Stock Portfolio: 15 Companies with At Least 30% Annual Growth Rates
In this article, we will take a look at the 15 stocks with at least 30% annual growth rates to consider for a growth stock portfolio.
5 Best Mid-Cap Growth Stocks To Buy Now
California-based cybersec company SentinelOne Inc (NYSE:S) shares have gained about 56% over the past six months. Earlier this month SentinelOne Inc (NYSE:S) posted strong third quarter results.
15 Best Fast Growth Stocks to Buy Now
In this article, we will take a look at the 15 best fast growth stocks to buy now.
Billionaire Hedge Funds
